8-cyclopentyl-6-hydrazinyl-2-((1-(methylsulfonyl)piperidin-4-yl)amino)pteridin-7(8H)-one

ID: ALA5281251

Max Phase: Preclinical

Molecular Formula: C17H26N8O3S

Molecular Weight: 422.52

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CS(=O)(=O)N1CCC(Nc2ncc3nc(NN)c(=O)n(C4CCCC4)c3n2)CC1

Standard InChI:  InChI=1S/C17H26N8O3S/c1-29(27,28)24-8-6-11(7-9-24)20-17-19-10-13-15(22-17)25(12-4-2-3-5-12)16(26)14(21-13)23-18/h10-12H,2-9,18H2,1H3,(H,21,23)(H,19,20,22)

Standard InChI Key:  XCCCFEGJPRCHRL-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    0.3586    1.0468    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0732    1.4591    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7851    1.0472    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7851    0.2220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0750   -0.1897    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3586    0.2183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4998   -0.1905    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2144    0.2220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2144    1.0471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4998    1.4598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9290   -0.1905    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.4998   -1.0157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3559   -0.1942    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0705    0.2183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7851   -0.1942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4998    0.2183    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4998    1.0435    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7851    1.4561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0705    1.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2144    1.4561    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9290    1.0435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8010    2.1721    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6270    2.1721    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9290    1.4598    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9290    2.2849    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.1670   -1.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9122   -2.2849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0873   -2.2849    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8325   -1.5004    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  6  5  2  0
  1  6  1  0
  4  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  2  0
  3 10  1  0
  8 11  2  0
 12  7  1  0
  6 13  1  0
 13 14  1  0
 15 14  1  0
 16 15  1  0
 17 16  1  0
 18 17  1  0
 19 18  1  0
 14 19  1  0
 17 20  1  0
 20 21  1  0
 20 22  2  0
 20 23  2  0
  9 24  1  0
 24 25  1  0
 26 12  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 12  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5281251

    ---

Associated Targets(Human)

CCNE1 Tchem Cyclin-dependent kinase 2/cyclin E (1410 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK4 Tclin Cyclin-dependent kinase 4/cyclin D1 (2340 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCND3 Tchem CDK6/cyclin D3 (897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 422.52Molecular Weight (Monoisotopic): 422.1849AlogP: 0.42#Rotatable Bonds: 5
Polar Surface Area: 148.13Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: HBA (Lipinski): 11HBD (Lipinski): 4#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 4.65CX LogP: -1.06CX LogD: -1.06
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.46Np Likeness Score: -1.59

References

1. Wang X, Ding L, Jiang H, Yuan X, Xiang L, Tang C..  (2023)  Synthesis and biological evaluation of novel pteridin-7(8H)-one derivatives as potent CDK2 inhibitors.,  88  [PMID:37060933] [10.1016/j.bmcl.2023.129284]

Source